Title |
Safety of regular formoterol or salmeterol in children with asthma: an overview of Cochrane reviews
|
---|---|
Published in |
Cochrane database of systematic reviews, October 2012
|
DOI | 10.1002/14651858.cd010005.pub2 |
Pubmed ID | |
Authors |
Christopher J Cates, Marta Oleszczuk, Elizabeth Stovold, L. Susan Wieland |
Abstract |
Two large surveillance studies in adults with asthma have found an increased risk of asthma-related mortality in those who took regular salmeterol as monotherapy in comparison to placebo or regular salbutamol. No similar sized surveillance studies have been carried out in children with asthma, and we remain uncertain about the comparative safety of regular combination therapy with either formoterol or salmeterol in children with asthma. |
X Demographics
The data shown below were collected from the profiles of 8 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
Country | Count | As % |
---|---|---|
Colombia | 1 | 13% |
United Kingdom | 1 | 13% |
Canada | 1 | 13% |
United States | 1 | 13% |
Australia | 1 | 13% |
Unknown | 3 | 38% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 5 | 63% |
Practitioners (doctors, other healthcare professionals) | 2 | 25% |
Scientists | 1 | 13% |
Mendeley readers
The data shown below were compiled from readership statistics for 140 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
Country | Count | As % |
---|---|---|
Colombia | 2 | 1% |
United Kingdom | 1 | <1% |
Peru | 1 | <1% |
Unknown | 136 | 97% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Student > Master | 22 | 16% |
Researcher | 14 | 10% |
Student > Bachelor | 12 | 9% |
Student > Ph. D. Student | 10 | 7% |
Student > Postgraduate | 8 | 6% |
Other | 18 | 13% |
Unknown | 56 | 40% |
Readers by discipline | Count | As % |
---|---|---|
Medicine and Dentistry | 41 | 29% |
Nursing and Health Professions | 12 | 9% |
Pharmacology, Toxicology and Pharmaceutical Science | 6 | 4% |
Social Sciences | 4 | 3% |
Psychology | 4 | 3% |
Other | 9 | 6% |
Unknown | 64 | 46% |
Attention Score in Context
This research output has an Altmetric Attention Score of 6. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 26 October 2016.
All research outputs
#6,265,283
of 25,457,297 outputs
Outputs from Cochrane database of systematic reviews
#7,568
of 11,499 outputs
Outputs of similar age
#46,196
of 193,432 outputs
Outputs of similar age from Cochrane database of systematic reviews
#144
of 224 outputs
Altmetric has tracked 25,457,297 research outputs across all sources so far. Compared to these this one has done well and is in the 75th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 11,499 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 40.0. This one is in the 34th percentile – i.e., 34% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 193,432 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 76% of its contemporaries.
We're also able to compare this research output to 224 others from the same source and published within six weeks on either side of this one. This one is in the 35th percentile – i.e., 35% of its contemporaries scored the same or lower than it.